Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report ; volume:11 ; number:1 ; day:16 ; month:1 ; year:2018 ; pages:1-5 ; date:12.2018
BMC Research Notes / Biomed Central; 11, Heft 1 (16.1.2018), 1-5, 12.2018
- Keyword
-
Atemwegskrankheit
Atemnot
- Creator
-
Yamada, Kazuhiro
- Contributor
-
Asai, Kazuhisa
Okamoto, Atsuko
Watanabe, Tetsuya
Kanazawa, Hiroshi
Ohata, Mai
Ohsawa, Masahiko
Hirata, Kazuto
SpringerLink (Online service)
- DOI
-
10.1186/s13104-018-3146-7
- URN
-
urn:nbn:de:1111-201802283352
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yamada, Kazuhiro
- Asai, Kazuhisa
- Okamoto, Atsuko
- Watanabe, Tetsuya
- Kanazawa, Hiroshi
- Ohata, Mai
- Ohsawa, Masahiko
- Hirata, Kazuto
- SpringerLink (Online service)
Other Objects (12)
COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis
Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis
The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
Focusing on diffuse (interstitial) lung disease: a rapidly evolving field
Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease
Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient
Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study
Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review
COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis
Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis
The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
Focusing on diffuse (interstitial) lung disease: a rapidly evolving field
Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease
Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient
Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study
Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review
COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis
Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis
The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
Focusing on diffuse (interstitial) lung disease: a rapidly evolving field
Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease
Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient
Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study